
GE Imaging is a business brand of GE HealthCare Technologies, Inc., a publicly traded medical technology company listed on Nasdaq under the ticker GEHC. The brand covers GE HealthCare's largest segment, medical imaging systems including MRI, CT, X-ray, and molecular imaging. The parent reported approximately $20.1 billion in FY2025 revenue.
Parent Company
Founded
2023
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| GE Imaging | GE HealthCare Technologies Inc. | Brand division |
GE's medical imaging business dates to the company's early X-ray work in the twentieth century, built inside General Electric's medical systems division into one of the two largest imaging franchises in the world alongside Siemens Healthineers. Its product lines include SIGNA MRI systems, Revolution CT scanners, and X-ray and molecular imaging platforms.
When GE spun off GE HealthCare Technologies in January 2023, the imaging business became the new public company's largest segment and its commercial identity for the equipment side of the portfolio. Under GE HealthCare the segment has continued launching systems including the Revolution Ascend CT platform and advanced molecular imaging for theranostics.
What does GE HealthCare do?
GE HealthCare Technologies Inc. develops, manufactures, and sells medical imaging, diagnostics, and healthcare IT solutions. The company operates through four segments: Imaging (MRI, CT, X-ray), Ultrasound, Patient Care Solutions (patient monitoring, healthcare IT), and Pharmaceutical Diagnostics (contrast agents, radiopharmaceuticals). GE HealthCare serves customers in over 160 countries.
Is GE HealthCare publicly traded?
Yes, GE HealthCare Technologies Inc. is publicly traded on the Nasdaq stock exchange under ticker GEHC. The company was spun off from General Electric on January 4, 2023, and has been independently traded since. General Electric does not retain a significant stake.
Who is the CEO of GE HealthCare?
Peter Arduini serves as President and CEO of GE HealthCare. He was appointed to lead GE's healthcare division in 2022 ahead of the January 2023 spinoff and has continued as CEO of the independent company.
What is GE HealthCare's annual revenue?
GE HealthCare reported revenue of $20.1 billion for fiscal year 2025, up from $19.6 billion in 2024. Net income for 2025 was $2.0 billion. The company's growth was driven by strong demand for medical imaging equipment, AI-enabled imaging solutions, and pharmaceutical diagnostics products.
How was GE HealthCare created?
GE HealthCare was created through the spinoff of General Electric's healthcare division on January 4, 2023. The spinoff was part of GE's broader restructuring, which also created GE Vernova (April 2024) and GE Aerospace as independent companies.
What acquisitions has GE HealthCare made recently?
In 2025, GE HealthCare acquired Impact Medical's NMPA-approved AI software for CT imaging analysis, strengthening its position in the Chinese healthcare AI market. The company has also invested in AI-enabled imaging products and digital health platforms.
Where is GE HealthCare headquartered?
GE HealthCare is headquartered in Chicago, Illinois, USA. The company has manufacturing facilities in the United States, United Kingdom, France, China, and India, and serves customers in over 160 countries.
Who owns GE HealthCare?
GE HealthCare is a publicly traded company with a dispersed shareholder base. Institutional investors hold the majority of shares, with no single controlling shareholder. General Electric does not retain a significant stake following the spinoff.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Boston Scientific | USA | 1979 | Mass market | Global | All Genders | |
| Zimmer Biomet | USA | 2010 | Mass market | Global | All Genders | |
| Stryker | USA | 1971 | Market leader | United states | All Genders | |
| Siemens | Germany | 2018 | Premium | Global | All-ages | |
| Stryker | USA | 1941 | Market leader | Global | All Genders | |
| Ge Healthcare | USA | 2023 | Mass market | Global | All Genders |
Healthcare PharmaceuticalsOwned by Boston Scientific Corporation
Corporate brand of Boston Scientific Corporation, the Marlborough, Massachusetts medical device maker behind WATCHMAN and FARAPULSE.
Healthcare PharmaceuticalsOwned by Zimmer Biomet Holdings, Inc.
Medical device company focused exclusively on foot and ankle orthopedic surgery. Founded in 2010 and acquired by Zimmer Biomet in 2025 for approximately $1.1 billion.
Healthcare PharmaceuticalsOwned by Stryker Corporation
Patient care and infection prevention brand owned by Stryker since 2016, maker of prepackaged bathing systems, oral care, and skin protection products.
Healthcare PharmaceuticalsOwned by Siemens AG
German medical technology and healthcare equipment company providing diagnostic imaging and laboratory diagnostics, owned by Siemens AG.
Healthcare PharmaceuticalsOwned by Stryker Corporation
Flagship medical technology brand of Stryker Corporation, founded in 1941 and a global leader in orthopaedic implants and surgical equipment.
Healthcare PharmaceuticalsOwned by GE HealthCare Technologies Inc.
Pharmaceutical Diagnostics business of GE HealthCare, producing contrast agents and molecular imaging tracers including Omnipaque, Clariscan, Vizamyl, and Flyrcado used in diagnostic scans worldwide.
Market Positioning: GE Imaging competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by GE HealthCare Technologies Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
Band-Aid is privately owned, unlike GE Imaging which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Kenvue
American brand of pain relief medication and analgesic drugs, flagship product of Kenvue Inc., the consumer health company spun off from Johnson and Johnson in 2023. Kimberly-Clark is acquiring Kenvue in a deal closed on November 2, 2026.
Tylenol is privately owned, unlike GE Imaging which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
Walgreens is privately owned, unlike GE Imaging which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Zocdoc, Inc.
Online healthcare marketplace where patients find in-network doctors and book appointments instantly, a private New York company valued at $1.8 billion.
Zocdoc is privately owned, unlike GE Imaging which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Kenvue
American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.
Benadryl is privately owned, unlike GE Imaging which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
Boots is privately owned, unlike GE Imaging which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.